In the modern, patient-centered health care system, patient-reported outcome measures, such as quality of life (QOL), are increasingly important to payers and regulatory agencies. There are unique problems in the assessment of the effect of glaucoma on vision-related QOL such that clinicians have long recognized a frequent discordance between patients’ reported symptoms and the results of standard automated perimetry. Patients’ QOL may be adversely affected in meaningful ways regardless of whether they are aware and report they have diminished vision. The characteristically gradual loss of vision that occurs in glaucoma may lead to an underreporting of symptoms by patients.
Tanna AP. Growing Evidence of the Importance of the Macula in Glaucoma. JAMA Ophthalmol. Published online May 25, 2017. doi:10.1001/jamaophthalmol.2017.1379